Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 6/24/2025 | $153.00 | Buy → Neutral | Arete | |
| 6/17/2025 | $3.70 → $3.80 | Sell → Neutral | Goldman | |
| 5/28/2025 | $112.00 | Buy → Hold | Deutsche Bank | |
| 5/28/2025 | $107.00 | Buy → Hold | China Renaissance | |
| 5/12/2025 | $130.00 | Buy | Deutsche Bank | |
| 3/21/2025 | $137.00 → $130.00 | Buy → Neutral | Nomura | |
| 3/17/2025 | Outperform → Neutral | Macquarie | ||
| 2/28/2025 | $22.00 → $40.00 | Neutral → Overweight | Analyst |
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), "Alibaba," "Alibaba Group" or the "Company") today announced the completion of its private offering (the "Bond Offering") of HK$12.023 billion aggregate principal amount of Zero Coupon Exchangeable Bonds due 2032 (the "Bonds") by reference to the ordinary shares of Alibaba Health Information Technology Limited ("Alibaba Health") that are listed on The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") (HKEX: 00241) ("AH Shares"). The Bonds were sold to certain non-U.S. persons in offshore transactions outside the United States in reliance on Regulation S under the U.S. Securitie
Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), "Alibaba," "Alibaba Group" or the "Company") today announced the pricing of its private offering (the "Bond Offering") of HK$12.023 billion aggregate principal amount of Zero Coupon Exchangeable Bonds due 2032 (the "Bonds") by reference to the ordinary shares of Alibaba Health Information Technology Limited ("Alibaba Health") that are listed on The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") (HKEX: 00241) ("AH Shares"). The Bonds were offered to certain non-U.S. persons in offshore transactions outside the United States in reliance on Regulation S under the U.S. Securitie
Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), "Alibaba," "Alibaba Group" or the "Company") today announced a proposed exchangeable bond offering (the "Bond Offering") by reference to the ordinary shares of Alibaba Health Information Technology Limited ("Alibaba Health") that are listed on The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") (HKEX: 00241) ("AH Shares"). Subject to market and other conditions, the Company proposes to issue approximately HK$12 billion aggregate principal amount of Zero Coupon Exchangeable Bonds due 2032 (the "Bonds") in a private offering to certain non-U.S. persons in offshore transactions
Arete downgraded Alibaba from Buy to Neutral and set a new price target of $153.00
Goldman upgraded NIO from Sell to Neutral and set a new price target of $3.80 from $3.70 previously
Deutsche Bank downgraded PDD Holdings from Buy to Hold and set a new price target of $112.00
BEIJING, July 1, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with a strong Internet foundation, today announced the appointment of Mr. Haijian He as Chief Financial Officer of the Company, effective immediately. Concurrently, Mr. Junjie He will step down from his position as Interim Chief Financial Officer and assume the role of Senior Vice President in charge of human resources and administrative functions. In addition, Ms. Shanshan Cui will serve as Secretary General to the Organizational Culture Committee of Baidu. Mr. Robin Yanhong Li, Baidu's Co-founder and CEO, commented, "We are
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Eme
The new face of wealth management creates ai powered software to drive optimization; membership is increasing 20% MoM, Appoints Chris Davidson of House Call Pro as CTO MCLEAN, Va., Nov. 26, 2024 /PRNewswire/ -- Range, the all-in-one AI WealthTech platform, raised $28 million in Series B funding, led by Cathay Innovation and joined by Gradient Ventures and other investors. This round brings the company's total funding to $40 million. Traditional financial advisors have offered the same types of wealth management services to consumers for decades. Range is overhauling the sector
SHANGHAI, June 03, 2025 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE:NIO, HKEX: 9866, SGX: NIO)) ("NIO" or the "Company"), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for the first quarter ended March 31, 2025. Operating Highlights for the First Quarter of 2025 Vehicle deliveries were 42,094 in the first quarter of 2025, consisting of 27,313 vehicles from the Company's premium smart electric vehicle brand NIO and 14,781 vehicles from the Company's family-oriented smart electric vehicle brand ONVO, representing an increase of 40.1% from the first quarter of 2024, and a decrease of 42.1% from the fourth quarter of 2
Quarterly total revenues reached RMB25.9 billion (US$3.6 billion)1Quarterly deliveries reached 92,864 vehicles BEIJING, China, May 29, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter ended March 31, 2025. Operating Highlights for the First Quarter of 2025 Total deliveries for the first quarter of 2025 were 92,864 vehicles, representing a 15.5% year-over-year increase. 2025 Q1 2024 Q4 2024 Q3 2024 Q2 Deliveries 92,864 158,696 152,831 108,581 2024 Q1 2023 Q4 2023 Q3 2023 Q2 Deliveries 80,400 131,805 105,108 86,533
DUBLIN and SHANGHAI, May 27, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Total revenues in the quarter were RMB95,672.2 million (US$1 13,184.0 million), an increase of 10% from RMB86,812.1 million in the same quarter of 2024.Operating profit in the quarter was RMB16,085.6 million (US$2,216.7 million), a decrease of 38% from RMB25,973.7 million in the same quarter of 2024. Non-GAAP2 operating profit in the quarter was RMB18,259.7 million (US$2,516.3 million), a decrease of 36% from RMB28,552.2 million in the same quarter o
SC 13G/A - Alibaba Group Holding Ltd (0001577552) (Filed by)
SC 13G/A - Alibaba Group Holding Ltd (0001577552) (Subject)
SC 13D/A - Baidu, Inc. (0001329099) (Filed by)